Asia-Pacific hepatitis C market to surpass $8.3 billion by 2023, says GBI Research. The hepatitis C market across the Asia-Pacific (APAC) region, which includes India, China, Australia, South Korea, and Japan is forecast to grow from $5.3 billion in 2016 to $8.3 billion by 2023, at a compound annual growth rate of 6.4 percent, according to…
Roche Pulls Ahead in Oncology, Expected to Remain Market Leader Until 2023
Roche will remain oncology market leader to 2023, in an increasingly fragmented but growing therapy area, says GBI Research. None of the products due to enter the oncology market by 2023 are expected to reach the same levels of success as the highest revenue-generating drugs currently in the market—such as Revlimid, Opdivo, and Avastin—according to…
2023 Forecast: Asia-Pacific Asthma Market to Hit $6B as Manufacturers Address Unmet Needs
Asia-Pacific asthma market will hit $6 billion by 2023 as manufacturers look to address unmet needs, says GBI Research. The Asia-Pacific (APAC) asthma therapeutics market, which covers India, China, Australia, South Korea and Japan, is expected to grow significantly from $4.1 billion in 2016 to around $6 billion by 2023, representing a compound annual growth…
Hematological Cancers Treatment: Oncology Pipeline with the Most Potential
Risk of Failure Pushes First-In-Class Innovations as Key Strategy for Pharma Companies
Research: Breast Cancer Market Heading toward $2.7B in Southeast Asia
Rheumatoid Arthritis Market in Southeast Asia to Reach $1.44B by 2022
Antibacterial Drugs Market to Hit $35.6B by 2022
Asia-Pacific Seasonal Influenza Vaccines Market to Surpass $1.7B by 2022
Research: Type 2 Diabetes Mellitus Market Ripe for Investment
US to Lose Dominance of Global Generics Market as Emerging Economies Take Over
Although the US is currently the largest generic drugs market by revenue globally, this is expected to change gradually, and dominance will soon shift to emerging markets including India, China, and Brazil, according to a survey from business intelligence provider GBI Research. The company’s latest report states that, according to an extensive survey of 47…
U.S. to Lose Dominance of Global Generics Market as Emerging Economies Take Over
Although the US is currently the largest generic drugs market by revenue globally, this is expected to change gradually, and dominance will soon shift to emerging markets including India, China, and Brazil, according to a survey from business intelligence provider GBI Research. The company’s latest report states that, according to an extensive survey of 47…
2022 Forecast: Diabetes & Obesity Therapeutics Market to Reach $163.2B
The global market for diabetes mellitus and obesity is set to rise from $70.8 billion in 2015 to $163.2 billion by 2022, at a strong compound annual growth rate of 12.7 percent, according to business intelligence firm GBI Research. The company’s latest report states that although this growth is largely attributable to a large increase…
Chronic Pain Treatment Pipeline Could Yield Innovative Alternatives to Opioids
Although opioids continue to dominate the chronic pain market, adverse events associated with the drug such as the potential for abuse mean the treatment space is rife with unmet needs, which is encouraging pharmaceutical companies to explore innovative alternatives to opioids, according to business intelligence provider GBI Research. The company’s latest report states that while…
Diabetes Complications Pipeline: Comprised Largely of Innovative First-in-Class Products
The diabetes complications space has high potential for changes and improvements as it becomes more diverse, with 30% of diabetic complication products in active development considered to be first-in-class, according to business intelligence provider GBI Research. According to the company’s latest report*, the market for diabetic complications is predominantly composed of therapies that symptomatically treat…
Hematological Cancers Market Expected to Exceed $70 Billion by 2022
The market for hematological cancers, which covers leukemia, lymphoma and myeloma, is expected to more than double from $30.7 billion in 2015 to $70.1 billion by 2022, representing a compound annual growth rate of 12.5%, according to business intelligence provider GBI Research. The company’s latest report* states that this strong growth will occur in spite…
Global Viral Infections Market to Reach $117.6 Billion by 2021
The global viral infections market will grow from $74 billion in 2014 to $117.6 billion by 2021, representing a compound annual growth rate of 6.8%, according to business intelligence provider GBI Research. The company’s latest report* states that the expanding treatment population, which has resulted from improved treatment options and global initiatives to improve access…
Non-Hematological Cancer Treatments: Market Drivers
Alzheimer’s Disease Market in Asia-Pacific: 2021 Predictions
The Asia-Pacific (APAC) Alzheimer’s disease market will grow from $3 billion in 2014 to $5.1 billion in 2021, representing a robust Compound Annual Growth Rate of 7.9%, according to business intelligence provider GBI Research. The company’s latest report* states that the main driver of this impressive growth, which will occur across the APAC countries of…
Asthma Therapeutics Market in Asia-Pacific Region: 2021 Predictions
Parkinson’s Disease: 2021 Predictions & the Search for the Cure
How Pharma Companies Can Keep Up with Global Market Access Shifts
As the overall costs of drugs continue to increase and pricing pressures shift the dynamics of the healthcare market, pharmaceutical companies must analyze real-world trends in different treatment spaces, and assess existing and expected levels of competition, in order to gain optimal market access, says business intelligence provider GBI Research. According to the company’s latest…
Pancreatic Cancer Treatment Market to Reach $2.9 Billion by 2021
The treatment market for pancreatic cancer is set to grow from its current level of $1.9 billion to an impressive $2.9 billion by 2021, driven primarily by an increased prevalence of the disease, according to business intelligence provider GBI Research. The company’s latest report* states that this rise, which will occur across the eight major…
